Eagle Pharmaceuticals Financial Overview
Eagle Pharmaceuticals's market cap is currently $8.44M. The company's EPS TTM is $; its P/E ratio is ―; Eagle Pharmaceuticals is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.